构建强健骨骼：骨质疏松性骨折二级预防临床路径的评估
Building for better bones: evaluation of a clinical pathway in the secondary prevention of osteoporotic fractures.
作者信息
Sofie Saey, Yves Piette, Barbara Verstraete, Margareta Lambert, Raf Van Hoeyweghen, Bruno Vandekerckhove, Marc Haspeslagh, Veerle Grootaert
机构信息
Department of Pharmacy, AZ Sint Jan Brugge-Oostende AV, Bruges, Belgium.
Department of Rheumatology, AZ Sint Jan Brugge-Oostende AV, Bruges, Belgium.
出版信息
Eur J Hosp Pharm. 2018 Jul;25(4):210-213. doi: 10.1136/ejhpharm-2016-000906. Epub 2016 Sep 6.
OBJECTIVE
Osteoporosis is a common disease that is underdiagnosed and undertreated. A multidisciplinary intervention may improve the identification and treatment of osteoporosis and may consequently prevent secondary fractures.
METHOD
Retrospective, single-centre study comparing attitude to screening and treatment of patients admitted to the orthopaedic unit of the general hospital AZ Sint-Jan Brugge-Oostende AV (Belgium) before and after the implementation of a clinical pathway.
RESULTS
A total of 172 patients (86 before and 86 after) were included in this study. The implementation of the pathway resulted in an increase in bone mineral density tests performed, an increment in the number of referrals to a specialist in the field of osteoporosis, and an increase in prevention and treatment of osteoporosis.
CONCLUSION
The implementation of a clinical pathway coordinated and evaluated by a clinical pharmacist improved the identification, referral and treatment of osteoporosis in patients hospitalised due to low-impact fractures.
目的
骨质疏松症是一种常见疾病，存在诊断不足和治疗不足的情况。多学科干预可能会改善骨质疏松症的识别和治疗，从而预防继发性骨折。
方法
一项回顾性单中心研究，比较了比利时AZ Sint-Jan Brugge-Oostende AV综合医院骨科病房实施临床路径前后患者对筛查和治疗的态度。
结果
本研究共纳入172例患者（实施前86例，实施后86例）。该路径的实施导致骨密度检测次数增加、转介至骨质疏松症领域专家的人数增加以及骨质疏松症的预防和治疗增加。
结论
由临床药师协调和评估的临床路径的实施改善了因低能量骨折住院患者骨质疏松症的识别、转介和治疗。
Zotero 插件